Trends & Forecasts

Sitting Down With Steve Turley, Managing Director for the British and Irish Isles, UCB.

A podcast series lets listeners eavesdrop on a conversation between scientists in a bar

What impact will Brexit, a new US President, and a flood of new technologies have on the industry?

Steve Keen talks to us about Trump, China, free trade and globalization

The players and chips are ready, what can poker teach us about the biosimilars business?

Big pharma CEOs should be wary of because orphans are usually better off alone.

Sitting Down With... Carol Lynch, Global Head Biopharmaceuticals, Sandoz.

Genentech’s Cell Culture Biologics Drug Substance Plant 2 in Vacaville, California.

Why has Médecins Sans Frontières rejected an offer of free vaccines from Pfizer?

This article explains how an inline probe was used to monitor a granulation at three different scales to confirm that, in each case, the granules produced were the same size, and more importantly produced tablets of identical quality as quantified by hardness.